Short answer
MBX Biosciences, Inc. (MBX) filed an 8-K current report with the SEC on March 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results announced March 12, 2026.
MBX Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results announced March 12, 2026
- Details and key figures contained in Exhibit 99.1 press release: primary source for revenue, cash, and pipeline spend data
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MBX Biosciences, Inc. 8-K filings
Get the next MBX 8-K as it lands
Follow MBX for push alerts, or ask the research agent what this filing means.